BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 18664158)

  • 1. Skin directed therapy for mycosis fungoides: a review.
    Berthelot C; Rivera A; Duvic M
    J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
    Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
    Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art therapy of mycosis fungoides and Sézary syndrome.
    Kemme DJ; Bunn PA
    Oncology (Williston Park); 1992 Feb; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
    Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
    Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.
    Quéreux G; Brocard A; Saint-Jean M; Peuvrel L; Knol AC; Allix R; Khammari A; Renaut JJ; Dréno B
    J Am Acad Dermatol; 2013 Dec; 69(6):890-7. PubMed ID: 24041738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phototherapy of mycosis fungoides.
    Trautinger F
    Photodermatol Photoimmunol Photomed; 2011 Apr; 27(2):68-74. PubMed ID: 21392108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
    Vonderheid EC; Dellatorre DL; Van Scott EJ
    Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of mycosis fungoides: Part 2. Treatment.
    Smith BD; Wilson LD
    Oncology (Williston Park); 2003 Oct; 17(10):1419-28; discussion 1430, 1433. PubMed ID: 14606365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report.
    Hasson A; Navarrete-Dechent C; Nicklas C; Sazunic I
    Int J Dermatol; 2013 Dec; 52(12):1535-7. PubMed ID: 24134456
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood mycosis fungoides: a report of 20 cases from Turkey.
    Yazganoglu KD; Topkarci Z; Buyukbabani N; Baykal C
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):295-300. PubMed ID: 22176010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy and plaque phase mycosis fungoides.
    Fernández-Guarino M; Jaén P
    G Ital Dermatol Venereol; 2011 Dec; 146(6):457-61. PubMed ID: 22095177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
    de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
    Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphomatoid papulosis associated with plaque-stage and granulomatous mycosis fungoides.
    Kardashian JL; Zackheim HS; Egbert BM
    Arch Dermatol; 1985 Sep; 121(9):1175-80. PubMed ID: 4037844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.